SCHEMBL7995907

SCHEMBL7995907

O=C/C(=C/c1ccccc1)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.54
TSHR P16473 1/20 0.54
AKR1C1 Q04828 1/20 0.52
NQO2 P16083 2/20 0.50
MAPK1 P28482 2/20 0.48
TDP1 Q9NUW8 1/20 0.48
PRMT1 Q99873 1/20 0.47
LMNA P02545 3/20 0.44
MAPT P10636 2/20 0.44
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44
POLB P06746 1/20 0.44
HPGD P15428 1/20 0.44
HTT P42858 1/20 0.44
KMT2A Q03164 1/20 0.44
CYP2A6 P11509 1/20 0.44
AKR1C3 P42330 1/20 0.43
ESR1 P03372 1/20 0.42
PLIN1 O60240 1/20 0.42
BCHE P06276 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL566813 1.00 ALDH1A1 (0.54) ALDH1A1TSHRAKR1C1NQO2MAPK1
SCHEMBL566814 1.00 ALDH1A1 (0.54) ALDH1A1TSHRAKR1C1NQO2MAPK1
Hydrochloric Acid SCHEMBL11771744 0.98 ALDH1A1 (0.52) ALDH1A1TSHRAKR1C1NQO2MAPK1
SCHEMBL566757 0.88 ALDH1A1 (0.51) ALDH1A1TSHRNQO2MAPK1TDP1
SCHEMBL566758 0.88 ALDH1A1 (0.51) ALDH1A1TSHRNQO2MAPK1TDP1
SCHEMBL28593357 0.88 MAPT (0.56) ALDH1A1TSHRNQO2MAPTMEN1
SCHEMBL5725732 0.86 MEN1 (0.49) ALDH1A1TSHRAKR1C1NQO2MAPT
SCHEMBL22500964 0.86 MAOB (0.50) ALDH1A1TSHRAKR1C1NQO2MAPK1
SCHEMBL20400451 0.86 MAOB (0.50) ALDH1A1TSHRAKR1C1NQO2MAPK1
SCHEMBL3725584 0.86 CYP1B1 (0.50) ALDH1A1TSHRAKR1C1NQO2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9708310-B2 Phenanthroindolizidine and phenanthroquinolizidine alkaloid having a hydroxyl group on the phenanthrene ring thereof, preparation method and use thereof CHINA MEDICAL UNIVERSITY (TW) 2017-07-18 US claimed
US-20170152257-A1 PHENANTHROINDOLIZIDINE AND PHENANTHROQUINOLIZIDINE ALKALOID HAVING A HYDROXYL GROUP ON THE PHENANTHRENE RING THEREOF, PREPARATION METHOD AND USE THEREOF CHINA MEDICAL UNIVERSITY (TW) 2017-06-01 US claimed
CN-120682125-B 1-Hydroxy-1-sodium sulfonate structural compound based on cinnamaldehyde derivative, and preparation method and application thereof 中国农业大学 2026-05-15 CN disclosed
CN-117945820-A Method for synthesizing alpha, beta-unsaturated aldehyde compound by copper catalysis 江苏海洋大学 2024-04-30 CN disclosed
US-9708310-B2 Phenanthroindolizidine and phenanthroquinolizidine alkaloid having a hydroxyl group on the phenanthrene ring thereof, preparation method and use thereof CHINA MEDICAL UNIVERSITY (TW) 2017-07-18 US disclosed
US-20170152257-A1 PHENANTHROINDOLIZIDINE AND PHENANTHROQUINOLIZIDINE ALKALOID HAVING A HYDROXYL GROUP ON THE PHENANTHRENE RING THEREOF, PREPARATION METHOD AND USE THEREOF CHINA MEDICAL UNIVERSITY (TW) 2017-06-01 US disclosed
US-20110295019-A1 Method for Producing Hydroxymethyl Diphenyloxiranes and Corresponding 1-azolylmethyl-1,2-diphenyloxiranes BASF SE (DE) 2011-12-01 US disclosed
EP-0975224-A1 PROCESS AND COMPOSITIONS FOR ENHANCING RELIABILITY OF EXOGENOUS CHEMICAL SUBSTANCES APPLIED TO PLANTS MONSANTO COMPANY (US) 2000-02-02 EP disclosed
US-6020287-A USING MIXTURE OF HERBICIDE AND PHENYL-SUBSTITUTED OLEFIN COMPOUND MONSANTO COMPANY (US) 2000-02-01 US disclosed
WO-1998033385-A1 PROCESS AND COMPOSITIONS FOR ENHANCING RELIABILITY OF EXOGENOUS CHEMICAL SUBSTANCES APPLIED TO PLANTS MONSANTO COMPANY (US) 1998-08-06 WO disclosed
US-4920232-A CHEMICAL INTERMEDIATES BASF AKTIENGESELLSCHAFT (DE) 1990-04-24 US disclosed
US-4804785-A INTERMEDIATES FOR HYDROXYMETHYLOXIRANES BASF AKTIENGESELLSCHAFT (DE) 1989-02-14 US disclosed
US-4723042-A REARRANGEMENT OF AN OXYKETONE USING A PHOSPHORUS COMPOUND BASF AKTIENGESELLSCHAFT (DE) 1988-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170152257-A1 PHENANTHROINDOLIZIDINE AND PHENANTHROQUINOLIZIDINE ALKALOID HAVING A HYDROXYL GROUP ON THE PHENANTHRENE RING THEREOF, PREPARATION METHOD AND USE THEREOF H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, PAH, HIPK4 ALDH1A1 480/4885TSHR 2275/4885AKR1C1 1963/4885
US-20110295019-A1 Method for Producing Hydroxymethyl Diphenyloxiranes and Corresponding 1-azolylmethyl-1,2-diphenyloxiranes DHPS, HMOX2, HMOX1 ALDH1A1 11/4885TSHR 3708/4885AKR1C1 145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.